Ranking Profile - Hanmi Science Co Ltd

Introduction

Hanmi Science Co Ltd (Hanmi Science) is a pharmaceutical company. Its research, development and commercialization of various active pharmaceutical ingredients, key intermediates, Cephalosporin APIs and cephalosporin finished dosage forms in both prescription and over-the-counter markets. Its pipeline includes efocipegtrutide, hm15912, lapsglucagon and bh3120, among others. Hanmi Science prescription includes prescription drugs including antidepressants, NSAIDs, neuropathic pain, oral care, hair growth, anti-inflammatory, osteoporosis and diabetes, among others.The company supplies its products across the world. Hanmi Science is headquartered in Hwaseong, Gyeonggi, South Korea.

Company info

Country (HQ): South Korea
Sector: Pharmaceuticals and Healthcare
Market Cap (US$ m): 2,067
Revenue (US$ m): 810 (2022)

Innovation ranking

363

Innovation score

Closest peers in the Pharmaceuticals and Healthcare sector

Innovation Ranking

Company
Headquarters
Sector

Johnson & Johnson

United States

Pharmaceuticals and Healthcare

F. Hoffmann-La Roche Ltd

Switzerland

Pharmaceuticals and Healthcare

Hanmi Science Co Ltd

South Korea

Pharmaceuticals and Healthcare

EyeGate Pharmaceuticals Inc

United States

Pharmaceuticals and Healthcare

Shin Poong Pharm Co Ltd

South Korea

Pharmaceuticals and Healthcare

Are you ranked? Get the Innovation Ranking Report

  • Company Ranking Report
    • If your company is ranked you can get more detailed information about your ranking through the Innovation Ranking Report
    • Full company scorecard across the 3 pillars and 19 data indicators that make up the ranking score
    • Contextualised information on the company's standing in relation to peers
    • Key takeaways on the company's position in its sector, country and its standing in relation to key industry themes
    • Tips on how to use your ranking to tell a unique and compelling story in your marketing, benchmarking and hiring processes
  • Rosettes
  • Certificate of Achievement
  • Press release
Screenshot of Deal Makers